Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Kálmán Laki Doctoral School, University of Debrecen, Debrecen, Hungary.
J Biomol Struct Dyn. 2020 Oct;38(16):4718-4732. doi: 10.1080/07391102.2019.1688194. Epub 2019 Nov 12.
The activity of antithrombin (AT), a serpin protease inhibitor, is enhanced by heparin and heparin analogs against its target proteases, mainly thrombin, factors Xa and IXa. Considerable amount of information is available on the multistep mechanism of the heparin pentasaccharide binding and conformational activation. However, much of the details were inferred from 'static' structures obtained by X-ray diffraction. Moreover, limited information is available for the early steps of binding mechanism other than kinetic studies with various ligands. To gain insights into these processes, we performed enhanced sampling molecular dynamics (MD) simulations using the Gaussian Accelerated Molecular Dynamics (GAMD) method, applied previously in drug binding studies. We were able to observe the binding of the pentasaccharide idraparinux to a 'non-activated' AT conformation in two separate trajectories with low root mean square deviation (RMSD) values compared to X-ray structures of the bound state. These trajectories along with further simulations of the AT-pentasaccharide complex provided insights into the mechanisms of multiple conformational transitions, including the expulsion of the hinge region, the extension of helix D and the conformational behavior of the reactive center loop (RCL). We could also confirm the high stability of helix P in non-activated AT conformations, such states might play an important role in heparin binding. 'Generalized correlation' matrices revealed possible paths of allosteric signal propagation to the binding sites for the target proteases, factors Xa and IXa. Enhanced MD simulations of ligand binding to AT may assist the design of new anticoagulant drugs.Communicated by Ramaswamy H. Sarma.
抗凝血酶 (AT) 的活性可被肝素及其类似物增强,从而针对其靶蛋白酶(主要是凝血酶、因子 Xa 和因子 IXa)发挥作用。关于肝素五糖结合和构象激活的多步机制,已经有大量信息。然而,许多细节都是从 X 射线衍射获得的“静态”结构中推断出来的。此外,除了与各种配体的动力学研究外,对于结合机制的早期步骤,信息有限。为了深入了解这些过程,我们使用高斯加速分子动力学 (GAMD) 方法进行了增强采样分子动力学 (MD) 模拟,该方法以前曾用于药物结合研究。我们能够在两条单独的轨迹中观察到 pentasaccharide idraparinux 与“非激活”AT 构象的结合,与结合状态的 X 射线结构相比,这些轨迹的均方根偏差 (RMSD) 值较低。这些轨迹以及对 AT-五糖复合物的进一步模拟提供了对多种构象转变机制的深入了解,包括铰链区的排出、螺旋 D 的延伸以及反应中心环 (RCL) 的构象行为。我们还可以确认非激活 AT 构象中螺旋 P 的高度稳定性,这些状态可能在肝素结合中发挥重要作用。“广义相关”矩阵揭示了到靶蛋白酶(因子 Xa 和因子 IXa)结合位点的变构信号传递的可能途径。配体与 AT 结合的增强 MD 模拟可能有助于设计新型抗凝药物。由 Ramaswamy H. Sarma 传达。